Impact of the SCF signaling pathway on leukemia stem cell-mediated ATL initiation and progression in an HBZ transgenic mouse model.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 27340921)

Published in Oncotarget on August 09, 2016

Authors

Wakako Kuribayashi1,2,3, Kazuya Takizawa1, Kenji Sugata4, Madoka Kuramitsu1, Haruka Momose1, Eita Sasaki1, Yuki Hiradate1, Keiko Furuhata1, Yoshihisa Asada3, Atsushi Iwama2, Masao Matsuoka4, Takuo Mizukami1, Isao Hamaguchi1

Author Affiliations

1: Department of Safety Research on Blood and Biological Products, National Institute of Infectious Disease, Tokyo, Japan.
2: Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
3: Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
4: Laboratory of Virus Control, Institute for Virus Research, Kyoto University, Kyoto, Japan.

Articles cited by this

Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med (1997) 32.63

The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med (2001) 11.94

Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med (2004) 11.29

Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood (1977) 10.69

Primary bioassay of human tumor stem cells. Science (1977) 9.69

Identification of cells initiating human melanomas. Nature (2008) 8.28

A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A (2004) 6.84

Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell (2012) 5.44

A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8- triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J Immunol (1993) 4.44

JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells. Cell (2004) 4.28

Notch signaling controls the generation and differentiation of early T lineage progenitors. Nat Immunol (2005) 3.26

Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. Cancer Cell (2011) 3.12

Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J Clin Oncol (2002) 2.85

Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat Med (2006) 2.81

A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy. Immunity (2009) 2.64

The discovery of the first human retrovirus: HTLV-1 and HTLV-2. Retrovirology (2005) 2.62

ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J (1989) 2.62

Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo. Cancer Cell (2014) 2.44

Integrated molecular analysis of adult T cell leukemia/lymphoma. Nat Genet (2015) 2.44

JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal. Cancer Cell (2009) 2.41

Mechanisms of chemoresistance in cancer stem cells. Clin Transl Med (2013) 2.20

Identification of cancer stem cells in a Tax-transgenic (Tax-Tg) mouse model of adult T-cell leukemia/lymphoma. Blood (2009) 2.20

The cellular basis of the genetically determined hemopoietic defect in anemic mice of genotype Sl-Sld. Blood (1965) 2.14

Stem cell factor receptor/c-Kit: from basic science to clinical implications. Physiol Rev (2012) 2.13

Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells. Nat Genet (2006) 2.10

Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int J Cancer (2004) 2.04

Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level. Blood (2000) 1.88

Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage. Cell (2001) 1.79

VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol (2007) 1.79

HTLV-1 Tax induces expression of various immediate early serum responsive genes. Oncogene (1991) 1.71

Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. Blood (2008) 1.63

HBZ interacts with JunD and stimulates its transcriptional activity. FEBS Lett (2004) 1.63

Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor. Blood (2015) 1.56

Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev (2007) 1.54

HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog (2011) 1.53

Identification of aberrantly methylated genes in association with adult T-cell leukemia. Cancer Res (2004) 1.48

New therapeutic approaches for adult T-cell leukaemia. Lancet Oncol (2004) 1.43

Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int J Cancer (2000) 1.37

Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability. Blood (2009) 1.21

Human T-cell leukemia virus type I induces adult T-cell leukemia: from clinical aspects to molecular mechanisms. Cancer Control (2007) 1.19

The HBZ-SP1 isoform of human T-cell leukemia virus type I represses JunB activity by sequestration into nuclear bodies. Retrovirology (2007) 1.18

Constitutive activation of transcription factor AP-1 in primary adult T-cell leukemia cells. Blood (2000) 1.17

Malignant lymphoma, pseudolymphoma, and hematopoietic disorders of the female genital tract. Pathol Annu (1991) 1.16

Human T-lymphotropic virus type I in Japan. Lancet (1994) 1.16

The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma. Blood (2014) 1.14

A comprehensive review of the phenotype and function of antigen-specific immunoregulatory double negative T cells. J Autoimmun (2012) 1.02

T memory stem cells are the hierarchical apex of adult T-cell leukemia. Blood (2015) 0.99

Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia. J Exp Med (2010) 0.98

AP-1-Dependent miR-21 expression contributes to chemoresistance in cancer stem cell-like SP cells. Oncol Res (2010) 0.98

Early T-cell precursor leukemia/lymphoma in adults and children. Leuk Res (2013) 0.97

Identifying progression-associated genes in adult T-cell leukemia/lymphoma by using oligonucleotide microarrays. Int J Cancer (2004) 0.93

Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A). Br J Haematol (2014) 0.91

Critical role for TSLC1 expression in the growth and organ infiltration of adult T-cell leukemia cells in vivo. J Virol (2008) 0.90

CADM1 expression and stepwise downregulation of CD7 are closely associated with clonal expansion of HTLV-I-infected cells in adult T-cell leukemia/lymphoma. Clin Cancer Res (2014) 0.89

Leukemic T cells are specifically enriched in a unique CD3(dim) CD7(low) subpopulation of CD4(+) T cells in acute-type adult T-cell leukemia. Cancer Sci (2011) 0.86

HIV type 1 persistence in CD4- /CD8- double negative T cells from patients on antiretroviral therapy. AIDS Res Hum Retroviruses (2006) 0.86

Development of antibodies to HIV-1 is associated with an increase in circulating CD3+CD4-CD8- lymphocytes. Clin Immunol Immunopathol (1989) 0.85

Productive infection of double-negative T cells with HIV in vivo. Proc Natl Acad Sci U S A (1999) 0.85

Blasts from patients with acute myelogenous leukemia express functional receptors for stem cell factor. Blood (1992) 0.84

Expression of stem cell factor and its receptor in human fetal and adult ovaries. Fertil Steril (2004) 0.84

Notch1-induced T cell leukemia can be potentiated by microenvironmental cues in the spleen. J Hematol Oncol (2014) 0.83

The clonal evolution of leukemic stem cells in T-cell acute lymphoblastic leukemia. Curr Opin Hematol (2014) 0.81

Peripheral T/natural killer-cell lymphoma involving the female genital tract: a clinicopathologic study of 5 cases. Int J Hematol (2001) 0.81

Transcriptional activity of HTLV-I Tax influences the expression of marker genes associated with cellular transformation. Dis Markers (2001) 0.81

Expression of adult T-cell leukaemia-derived factor, a human thioredoxin homologue, in the human ovary throughout the menstrual cycle. Virchows Arch A Pathol Anat Histopathol (1992) 0.78

Immunology of chronic BVDV infections. Biologicals (2012) 0.77

Leukemia and ABC transporters. Adv Cancer Res (2015) 0.76

Articles by these authors

Integrated molecular analysis of adult T cell leukemia/lymphoma. Nat Genet (2015) 2.44

Downregulation of rRNA transcription triggers cell differentiation. PLoS One (2014) 0.89

Cancer stem cells in hepatocellular carcinoma: Therapeutic implications based on stem cell biology. Hepatol Res (2015) 0.87

Disulfiram eradicates tumor-initiating hepatocellular carcinoma cells in ROS-p38 MAPK pathway-dependent and -independent manners. PLoS One (2014) 0.86

HTLV-1 subgroups associated with the risk of HAM/TSP are related to viral and host gene expression in peripheral blood mononuclear cells, independent of the transactivation functions of the viral factors. J Neurovirol (2015) 0.79

A critical role for IL-17RB signaling in HTLV-1 tax-induced NF-κB activation and T-cell transformation. PLoS Pathog (2014) 0.78

Reevaluation of confirmatory tests for human T-cell leukemia virus Type 1 using a luciferase immunoprecipitation system in blood donors. Transfusion (2014) 0.78

Gene expression profiling of loss of TET2 and/or JAK2V617F mutant hematopoietic stem cells from mouse models of myeloproliferative neoplasms. Genom Data (2015) 0.77

Novel 1p tumour suppressor Dnmt1-associated protein 1 regulates MYCN/ataxia telangiectasia mutated/p53 pathway. Eur J Cancer (2014) 0.77

Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia. Nat Genet (2017) 0.77

Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity. Cancer Discov (2017) 0.76

Enhanced antibody-mediated neutralization of HIV-1 variants that are resistant to fusion inhibitors. Retrovirology (2016) 0.76

Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma. Oncotarget (2017) 0.75

Enhancement of anti-STLV-1/HTLV-1 immune responses through multimodal effects of anti-CCR4 antibody. Sci Rep (2016) 0.75

Loss of Pcgf5 Affects Global H2A Monoubiquitination but Not the Function of Hematopoietic Stem and Progenitor Cells. PLoS One (2016) 0.75

Experimental evaluation of the zoonotic infection potency of simian retrovirus type 4 using humanized mouse model. Sci Rep (2015) 0.75

Polycomb repressive complexes in hematological malignancies. Blood (2017) 0.75

Progerin impairs vascular smooth muscle cell growth via the DNA damage response pathway. Oncotarget (2017) 0.75

Regulation of tumour related genes by dynamic epigenetic alteration at enhancer regions in gastric epithelial cells infected by Epstein-Barr virus. Sci Rep (2017) 0.75

Prominin-1/CD133 expression as potential tissue-resident vascular endothelial progenitor cells in the pulmonary circulation. Am J Physiol Lung Cell Mol Physiol (2016) 0.75

Bmal1 regulates inflammatory responses in macrophages by modulating enhancer RNA transcription. Sci Rep (2017) 0.75

Possible role of intragenic DNA hypermethylation in gene silencing of the tumor suppressor gene NR4A3 in acute myeloid leukemia. Leuk Res (2016) 0.75